YTHDF1 promotes pancreatic cancer cell progression by enhancing SF3B2 translation though m 6 A modification
The Journal of Biochemistry · 2025
DOI: 10.1093/jb/mvaf018 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Biochemistry, 2025. Verfasst von Chunyang Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Fifth Clinical Medical School, Anhui Medical University, 81 Meishan Rd, Hefei 230032, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, RNA Splicing Factors, RNA-Binding Proteins, Adenosine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Key Scientific Research Foundation of the Education Department of Province of Anhui.
Abstract (Originalsprache)
N6-Methyladenosine (m6A), a pivotal RNA modification, plays a critical role in carcinogenesis across multiple cancer types. YT521-B homology domain family protein 1 (YTHDF1), a binding protein of m6A, facilitates the translation of downstream targets via m6A recognition. However, the involvement of YTHDF1 in pancreatic cancer progression and its mechanistic underpinnings remain poorly understood. In this study, we observed significant upregulation of YTHDF1 in pancreatic cancer cell lines (SW1990 and PANC-1) compared to the normal human pancreatic cell line hTERT-HPNE. Functional assays revealed that YTHDF1 knockdown markedly suppressed cell proliferation and invasion, whereas its overexpression enhanced these malignant phenotypes in both SW1990 and PANC-1 cells. Mechanistically, YTHDF1 interacted with coding sequence (CDS) region of splicing factor 3B subunit 2 (SF3B2), whereas YTHDF1 downregulation reduced SF3B2 protein levels without altering its mRNA expression, suggesting post-transcriptional regulation via m6A modification. Importantly, SF3B2 overexpression rescued the suppressed proliferation and invasion caused by YTHDF1 knockdown in SW1990 and PANC-1 cells. Collectively, our findings demonstrate that YTHDF1 drives pancreatic cancer progression by enhancing SF3B2 translation through m6A modification, thereby providing novel mechanistic insights and a potential therapeutic target for pancreatic cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Fifth Clinical Medical School, Anhui Medical University, 81 Meishan Rd, Hefei 230032, China.
- Department of Emergency Surgery, The Second People's Hospital of Wuhu, 4 Duchun Rd, Wuhu 241000, China.
- Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wannan Medical College, No. 2, Zheshan West Rd, Wuhu 241000, China.
Förderung
- Key Scientific Research Foundation of the Education Department of Province of Anhui
Zitieren
APA
Wang, C., Huang, K., Yang, J., Xu, Q., Kuai, J., Zhang, G., & Wang, X. (2025). YTHDF1 promotes pancreatic cancer cell progression by enhancing SF3B2 translation though m 6 A modification. The Journal of Biochemistry. https://doi.org/10.1093/jb/mvaf018
Vancouver
Wang C, Huang K, Yang J, Xu Q, Kuai J, Zhang G, et al. YTHDF1 promotes pancreatic cancer cell progression by enhancing SF3B2 translation though m 6 A modification. The Journal of Biochemistry. 2025. doi:10.1093/jb/mvaf018
BibTeX
@article{Wang2025,
author = {Wang, Chunyang and Huang, Kai and Yang, Jie and Xu, Qingchun and Kuai, Jiagao and Zhang, Guangxian and Wang, Xiaoming},
title = {YTHDF1 promotes pancreatic cancer cell progression by enhancing SF3B2 translation though m 6 A modification},
journal = {The Journal of Biochemistry},
year = {2025},
doi = {10.1093/jb/mvaf018}
}
EUVIMED